Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials

Salivary gland cancers (SGCs) are heterogeneous tumors, and precision oncology represents a promising therapeutic approach; however, its impact on SGCs remains obscure. This study aimed to establish a translational model for testing molecular-targeted therapies by combining patient-derived organoids...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Tomohiko, Ogawa, Takenori, Shiihara, Masahiro, Usubuchi, Hajime, Omori, Yuko, Hirose, Katsuya, Itoh, Taito, Yoshida, Takuya, Nakanome, Ayako, Okoshi, Akira, Higashi, Kenjiro, Ishii, Ryo, Rokugo, Masahiro, Wakamori, Shun, Okamura, Yasunobu, Kinoshita, Kengo, Katori, Yukio, Furukawa, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189274/
https://www.ncbi.nlm.nih.gov/pubmed/37207275
http://dx.doi.org/10.1016/j.isci.2023.106695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189274/
https://www.ncbi.nlm.nih.gov/pubmed/37207275
http://dx.doi.org/10.1016/j.isci.2023.106695

Ejemplares similares